Skip to content
Boston Collaborative Drug Surveillance Program (BCDSP)
  • Home
  • Services
  • Research
  • Our Team
  • History
  • Publications

Expert Opinion on Drug Safety

  • Home
  • Expert Opinion on Drug Safety

A review of the evidence on the risk of congenital malformations and neurodevelopmental disorders in association with antiseizure medications during pregnancy

Posted by By BCDSP July 28, 2021Posted inUncategorized
Journal: Expert Opinion on Drug Safety Authors: Carole A Marxer, Stephan Rüegg, Marlene S Rauch, Alice Panchaud, Christoph R Meier, Julia Spoendlin NLM Citation: Marxer CA, Rüegg S, Rauch MS, Panchaud A, Meier CR, Spoendlin…
Read More
  • @BCDSP_DRG on Twitter
  • BCDSP on LinkedIn
  • @bcdsp.bsky.social‬ on BlueSky
Boston Collaborative Drug Surveillance Program (BCDSP)

55 Waltham Street, Rear | Lexington, MA 02421 USA
Phone: +1 (781) 862-6660
E-mail: info@bcdsp.org

Copyright 2026 — Boston Collaborative Drug Surveillance Program (BCDSP). All rights reserved.
Scroll to Top